ADBiotech Co

ADBiotech Co Debt Growth

The Year-over-Year Debt Growth of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is -66.55 %. In the previous year, Year-over-Year Debt Growth was 18.19 % — a change of -465.78% (lower).

Debt Growth

-66.55 %

YoY

-465.78%

Last updated:

Year-over-Year Debt Growth of ADBiotech Co is 2025 -66.55 % . Year-over-Year Debt Growth of ADBiotech Co was 2024 18.19 % . It decreases by -465.78% lower compared to the previous year.

The ADBiotech Co Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2018
-10.40 KRW
Jan 1, 2019
-34.17 KRW
Jan 1, 2020
148.92 KRW
Jan 1, 2021
0.60 KRW
Jan 1, 2022
29.43 KRW
Jan 1, 2023
1.84 KRW
Jan 1, 2024
18.19 KRW
Jan 1, 2025
-66.55 KRW
The ADBiotech Co Debt Growth history
YEARDebt GrowthYoY
-66.55 %-465.78%
18.19 %+887.97%
1.84 %-93.74%
29.43 %+4,840.41%
0.60 %-99.60%
148.92 %-535.80%
-34.17 %+228.52%
-10.40 %-69.78%
-34.42 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Year-over-Year Debt Growth of ADBiotech Co is -66.55 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — ADBiotech Co

All Key Metrics — ADBiotech Co